Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (31-40 of 311) with videos related to

Pageof 32
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|March 5, 2011
Targeted therapy in head and neck cancerLisa Licitra, Cristiana Bergamini, Aurora Mirabile, et al.
Oral Oncology|December 20, 2008
Survival from salivary glands adenoid cystic carcinoma in European populationsLaura Ciccolallo, Lisa Licitra, Giulio Cantú, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?Lisa Licitra, Paolo Bossi, Laura Locati, et al.
British Journal of Cancer|January 24, 2018
Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'Paolo Bossi, Roberta Granata, Ester Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMichela Meregaglia, John Cairns, Lisa Licitra, et al.
The Oncologist|June 24, 2025
Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapyStefano Cavalieri, Arianna Ottini, Benedetta Lombardi Stocchetti, et al.
Current Opinion in Oncology|April 8, 2004
Head and neck tumors other than squamous cell carcinomaLisa Licitra, Laura D Locati, Paolo Bossi, et al.
Cancers of the Head & Neck|May 12, 2020
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreakCarlo Resteghini, Paola Maggioni, Vito Di Martino, et al.
Current Opinion in Otolaryngology & Head and Neck Surgery|March 23, 2006
Advances in the changing patterns of aetiology of head and neck cancersLisa Licitra, Chiara Rossini, Paolo Bossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Folate in head and neck squamous cell cancer chemoprevention: purposely left out?Paolo Bossi, Laura D Locati, Lisa Licitra, et al.
Pageof 32

Showing results (31-40 of 311) with videos related to

Sort By:
Pageof 32
Current Opinion in Otolaryngology & Head and Neck Surgery|March 5, 2011
Targeted therapy in head and neck cancerLisa Licitra, Cristiana Bergamini, Aurora Mirabile, et al.
Oral Oncology|December 20, 2008
Survival from salivary glands adenoid cystic carcinoma in European populationsLaura Ciccolallo, Lisa Licitra, Giulio Cantú, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2004
Cisplatin and fluorouracil concurrent to radiotherapy in nasopharyngeal cancer: is the schedule compatible?Lisa Licitra, Paolo Bossi, Laura Locati, et al.
British Journal of Cancer|January 24, 2018
Comment on 'Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer'Paolo Bossi, Roberta Granata, Ester Orlandi, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2018
The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluationMichela Meregaglia, John Cairns, Lisa Licitra, et al.
The Oncologist|June 24, 2025
Indirect comparison of TPF and GP induction chemotherapy regimens in nasopharyngeal carcinoma: a data-driven reassessment before the transition to induction chemoimmunotherapyStefano Cavalieri, Arianna Ottini, Benedetta Lombardi Stocchetti, et al.
Current Opinion in Oncology|April 8, 2004
Head and neck tumors other than squamous cell carcinomaLisa Licitra, Laura D Locati, Paolo Bossi, et al.
Cancers of the Head & Neck|May 12, 2020
Response of the Istituto Nazionale Tumori of Milan Head & Neck Cancer Unit to the COVID-19 outbreakCarlo Resteghini, Paola Maggioni, Vito Di Martino, et al.
Current Opinion in Otolaryngology & Head and Neck Surgery|March 23, 2006
Advances in the changing patterns of aetiology of head and neck cancersLisa Licitra, Chiara Rossini, Paolo Bossi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Folate in head and neck squamous cell cancer chemoprevention: purposely left out?Paolo Bossi, Laura D Locati, Lisa Licitra, et al.
Pageof 32